Platelet activity: An obstacle for successful PCI

Nature Reviews Cardiology

Volumn 6, Issue 6, 2009, Pages 391-392

  Gawaz, Meinrad ^a   Geisler, Tobias ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DRUG DERIVATIVE; TICLOPIDINE;

BLOOD; BLOOD CLOTTING PARAMETERS; CORONARY ARTERY DISEASE; DRUG COMBINATION; DRUG EFFECT; HUMAN; INSTRUMENTATION; NOTE; PATIENT SELECTION; RISK ASSESSMENT; RISK FACTOR; STENT; THROMBOCYTE ACTIVATION; THROMBOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ASPIRIN; CORONARY ARTERY DISEASE; DRUG THERAPY, COMBINATION; HUMANS; PATIENT SELECTION; PLATELET ACTIVATION; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; RISK ASSESSMENT; RISK FACTORS; STENTS; THROMBOSIS; TICLOPIDINE; TREATMENT OUTCOME;

EID: 69249203871     PISSN: 17595002     EISSN: 17595010     Source Type: Journal    
DOI: 10.1038/nrcardio.2009.76     Document Type: Article

References (10)

1. Spaulding, C. et al. Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N. Engl. J. Med. 355, 1093-1104 (2006).
2. Neumann, F. J. et al. Prospective evaluation of hemostatic predictors of subacute stent thrombosis after coronary Palmaz-Schatz stenting. J. Am. Coll. Cardiol. 27, 15-21 (1996).
3. Muller, I. et al. Prevalence of clopidogrel nonresponders among patients with stable angina pectoris scheduled for elective coronary stent placement. Thromb. Haemost. 89, 783-787 (2003).
4. Geisler, T. et al. Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation. Eur. Heart J. 27, 2420-2425 (2006).
5. Snoep, J. D. et al. Clopidogrel nonresponsiveness in patients undergoing percutaneous coronary intervention with stenting: a systematic review and metaanalysis. Am. Heart J. 154, 221-231 (2007).
6. Sibbing, D. et al. Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis. J. Am. Coll. Cardiol. 53, 849-856 (2009).
7. Gurbel, P A. et al. Clopidogrel effect on platelet reactivity in patients with stent thrombosis. J.Am. Coll. Cardiol. 46, 1827-1832 (2005).
8. Buonamici, P impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis. J. Am. Coll. Cardiol. 49, 2312-2317 (2007).
9. Hulot, J.-S. & Fuster, V. Personalized medicine for clopidogrel resistance? Nat. Rev. Cardiol. 6, 334-336 (2009).
10. Geisler, T. et al. The residual platelet aggregation after deployment of intracoronary stent (PREDiCT) score. J. Thromb. Haemost. 6, 54-61 (2008).